Xiang Yu | Regional Immunity | Best Researcher Award

Posted on by ScienceFather

Prof. Xiang Yu | Regional Immunity | Best Researcher Award

Prof. Xiang Yu, Hainan University, China

Prof. Xiang Yu is a distinguished immunologist and professor at Hainan University’s School of Biomedical Engineering. He specializes in regional immunity, with a focus on liver immunity and immune visualization. Holding a PhD from Huazhong University of Science and Technology, he has significantly contributed to tumor immunology and nanomedicine. Prof. Yu has published over 59 SCI-indexed papers, including highly cited works in Nature Communications and ACS Nano. His research innovations, including nanovaccines and biomimetic probes, have garnered international recognition. He has supervised numerous doctoral students and received multiple awards, including the Young Scholar Award from the Chinese Society of Immunology.

Publication Profile

Scopus

Orcid

Education 🎓📖

Prof. Xiang Yu obtained a Bachelor’s degree in Clinical Medicine from Wuhan University of Science and Technology in 2013. He later pursued a PhD in Biomedical Engineering at Huazhong University of Science and Technology, graduating in 2019. His doctoral research focused on immune microenvironment regulation, leading to groundbreaking findings in immune visualization and nanomedicine. During his academic journey, he developed expertise in tumor immunology, bio-nanotechnology, and immunotherapeutics. His education laid the foundation for his pioneering work in targeted liver immunity and innovative vaccine designs.

Experience 🏫🔬

Since 2019, Prof. Xiang Yu has been a professor of immunology at Hainan University, mentoring graduate students and leading cutting-edge research projects. His expertise in immune-targeted therapies has driven advancements in biomedical imaging and tumor vaccines. Over the years, he has published over 59 high-impact journal articles, collaborated on international research projects, and contributed to multiple patents. He also holds editorial roles in prestigious journals, serves as a reviewer for SCI-indexed publications, and has been an invited speaker at global immunology conferences.

Awards and Honors 🏆🎖

Prof. Yu has received four major awards, including the Young Scholar Award from the Chinese Society of Immunology. His groundbreaking research has been recognized with the Annual Best Paper Award by Journal of Nanobiotechnology. He has also earned two ESI Highly Cited Paper awards, highlighting his significant impact in immunology and nanomedicine. His students have won national and municipal prizes in academic competitions under his mentorship.

Research Focus 🔬🧬

Prof. Xiang Yu’s research revolves around regional immunity, particularly liver immunity and immune visualization. His work includes bee venom-based liver endothelial targeting, whole-tumor-cell nanovaccines, and biomimetic probes for inflammatory diseases. His studies have led to novel immune regulation strategies for cancer metastasis and autoimmune disorders. His interdisciplinary approach combines bioengineering, nanotechnology, and immunology to develop innovative diagnostic and therapeutic solutions.

Publication Top Notes

  • Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis (Nature Communications, 2019)

  • Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response (Nature Communications, 2020)

  • Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles (Light: Science & Applications, 2020)

  • Biomimetic nanoplatform with selectively positioned indocyanine green for accurate sentinel lymph node imaging (Nanoscale, 2023)

  • Aptamer-modified melittin micelles efficiently inhibit osteosarcoma deterioration by inducing immunogenic cell death (Colloids and Surfaces B: Biointerfaces, 2025)

  • Breaking CHIPS-Mediated immune evasion with tripterin to promote neutrophil chemotaxis against MRSA infection (International Immunopharmacology, 2024)

  • Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Monobenzone-Induced Vitiligo in Mice (International Journal of Molecular Sciences, 2024)

  • Mitochondrial stress response in drug-induced liver injury (Molecular Biology Reports, 2021)

  • Hematoxylin and eosin staining of intact tissues via delipidation and ultrasound (Scientific Reports, 2018)

 

 

Omid Yeganeh | Immunology and Microbiology | Best Scholar Award

Posted on by ScienceFather

Omid Yeganeh | Immunology and Microbiology | Best Scholar Award

Dr Omid Yeganeh, Islamic Azad University, Iran

Dr. Omid Yeganeh is a microbiologist with a Ph.D. in Microbiology from the Islamic Azad University, Tehran, Iran. He also holds an M.Sc. in Microbiology and a B.Sc. in Cellular and Molecular Biology. As a researcher at the Monoclonal Antibody Research Center, Avicenna Research Institute, he specializes in producing monoclonal antibodies against various molecules, including PSA, prolactin, ferritin, and sperm surface antigens. Dr. Yeganeh serves as a technical editor and associate editor for several journals, contributing to the advancement of microbiological research. His work has significantly impacted the field of immunology and antibody development. 🔬🧬💉

Publication profile

google scholar

Education

Dr. Omid Yeganeh holds an impressive academic background, earning a Ph.D. in Microbiology from the Department of Microbiology at the Islamic Azad University, Tehran, Iran. His M.Sc. in Microbiology and B.Sc. in Cellular and Molecular Biology with a focus on Microbiology further enhance his foundational knowledge in the field. As a member of the Monoclonal Antibody Research Center at the Avicenna Research Institute, he is well-versed in cutting-edge research methodologies.

Research Experience

Dr. Yeganeh’s extensive experience as a researcher at the Monoclonal Antibody Research Center showcases his commitment to advancing the field of microbiology and immunology. His role as a technical editor and associate editor for scientific journals highlights his expertise and active participation in academic discourse. His hands-on research experience equips him with a practical understanding of the latest methodologies in microbiology.

Research Activities

His work focuses on the production of monoclonal antibodies against various clinically significant molecules, including PSA, prolactin, and sperm surface antigens. He has successfully produced monoclonal antibodies against over 100 different peptides, showcasing his technical expertise in hybridoma techniques and cell culture. This innovative research has the potential to contribute significantly to diagnostic and therapeutic applications in medicine.

Congress Participation

Dr. Yeganeh actively participates in international congresses, such as the 15th Virtual International Congress of Immunology & Allergy and the ICIA 2023, where he presents his research findings. His engagement in these forums not only broadens his professional network but also enhances the visibility of his research contributions on a global scale.

Research focus

Dr. Omid Yeganeh is a prominent researcher with a focus on medical biotechnology, particularly in immunology and microbiology. His work includes the production and characterization of monoclonal antibodies against various human proteins and pathogens, highlighting his expertise in antibody development for diagnostic and therapeutic applications. He has also investigated infectious diseases, including the emergence of antibiotic-resistant bacteria, contributing to the understanding of microbial drug resistance. His research significantly impacts both clinical diagnostics and therapeutic strategies. 🧬🔬📊

Publication top notes

Intra-and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction …

The Challenge of Global Emergence of Novel Colistin-Resistant Escherichia coli ST131

Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta‐specific 1

A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of Labbafinejad …

Production and characterization of a murine monoclonal antibody against human ferritin

Skull base aneurysmal bone cyst presented with foramen jugular syndrome and multi-osseous involvement

Fibro-osseous lesions of the skull base in the pediatric population

Production and characterization of monoclonal antibodies against human prostate specific antigen

Conclusion

Dr. Omid Yeganeh’s academic credentials, research experience, and extensive publication record make him a highly suitable candidate for the Best Researcher Award. His innovative research in monoclonal antibody production and his commitment to advancing scientific knowledge in microbiology not only demonstrate his capabilities as a researcher but also indicate his potential for future contributions to the field.

 

Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Posted on by ScienceFather

Prof. Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Prof. Ammu Kutty Radhakrishnan, Monash University Malaysia, Malaysia

 

Prof. Ammu Kutty Radhakrishnan is a distinguished immunologist with a PhD from the University of Cambridge (1994), an MSc in Biochemistry (1990), and a BSc (First Class Honours) from the University of Malaya (1987). Currently, a Professor of Immunology at Monash University Malaysia, she has over 25 years of academic leadership and research experience. Prof. Ammu specializes in immunotherapy and food as medicine research, serving as Head of this research strength. Her career spans significant roles at International Medical University and Oxford. She is a research consultant, active in COVID-19 vaccine efforts, and supervises PhD and MSc students. 🌿🧬📚

 

Publication Profile

Google Scholar

Academic Excellence

Prof. Ammu Kutty Radhakrishnan has an exceptional academic background, with a PhD in Immunology from the University of Cambridge (1994) and degrees in Biochemistry from the University of Malaya. Her education forms a solid foundation for her expertise in immunology and biomedical sciences, contributing to her distinguished career.

Professional Experience

Prof. Radhakrishnan has held key roles, such as Professor at Monash University Malaysia and the International Medical University (IMU). Her leadership in academic programs, such as head of the Food as Medicine Research Strength and chief examiner roles, showcases her commitment to advancing education and research.

Research Contributions

Prof. Radhakrishnan has supervised numerous PhD and Master’s students, guiding 39 doctoral and 20 master’s research projects to completion. Her extensive research supervision experience highlights her dedication to fostering scientific inquiry and innovation. Additionally, her collaborative efforts with industry partners demonstrate her ability to apply research to real-world problems.

Conclusion

Prof. Ammu Kutty Radhakrishnan’s outstanding academic credentials, extensive research supervision, leadership roles, and global health contributions, she is an ideal candidate for the Best Researcher Award. Her work in immunology, biomedicine, and collaboration with industry partners demonstrates her excellence in both academic and applied research, making her a worthy contender for this prestigious recognition.

 

Publication Top Notes  

  • Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals (2010) – 292 citations 🧪
  • Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59 (1994) – 259 citations 🧬
  • Rind of the rambutan, Nephelium lappaceum, a potential source of natural antioxidants (2008) – 193 citations 🍇
  • Current concepts of neurodegenerative mechanisms in Alzheimer’s disease (2018) – 176 citations 🧠
  • Bioactive Compounds: Natural Defense Against Cancer? (2019) – 169 citations 🌿
  • Protective mechanisms of flavonoids in Parkinson’s disease (2015) – 162 citations 🧑‍⚕️
  • Tocotrienol research: past into present (2012) – 157 citations 🌰
  • Standardised Mangifera indica extract is an ideal antioxidant (2009) – 149 citations 🥭
  • Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson’s disease (2020) – 128 citations 🚀
  • Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice (2004) – 126 citations 🧫
  • Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity (2013) – 124 citations 🧪

 

Hadi Hassannia | Immunology | Best Researcher Award

Posted on by ScienceFather

Dr. Hadi Hassannia | Immunology | Best Researcher Award

Dr. Hadi Hassannia, Mazandaran University of Medical Sciences, Iran

Dr. Hadi Hassannia is a prominent researcher at the Amol Faculty of Paramedical Sciences and the Immunogenetic Research Center of Mazandaran University of Medical Sciences in Sari, Iran. His research focuses on cancer immunotherapy and vaccine development, with significant publications on tumor inhibition and insulin-producing cells from stem cells. Dr. Hassannia possesses advanced technical skills in genetic engineering, antibody production, and molecular techniques. His experience as a lab technician in diagnostic laboratories has enriched his practical knowledge in various fields, including hematology and immunology. He is committed to advancing cancer research and therapeutic approaches. 🧬🔬💉

 

Publication Profile

Google Scholar

Work Experience

Dr. Hassannia has a robust work history, having served as a lab technician in various diagnostic laboratories in governmental hospitals from 2009 to 2017. His practical experience in clinical settings enriches his research with a real-world perspective, further bridging the gap between laboratory findings and clinical applications.

Technical Skills

Dr. Hassannia possesses a diverse skill set that enhances his research capabilities:

Genetic Engineering: He has significant experience in genetic engineering, including protein manipulation and monoclonal antibody production.

Immunological Techniques: Proficient in advanced immunological techniques such as flow cytometry, Western blotting, and ELISA, he is well-equipped to conduct comprehensive immunological research.

Molecular Techniques: His expertise extends to molecular biology techniques like PCR and gene transfection, which are essential for cancer research and therapeutic development.

Laboratory Animal Handling: His experience with laboratory animals allows him to perform complex experiments, including tumor induction, vital for his research in cancer models.

 

Research Interests

Cancer Vaccine Development: His work in developing cancer vaccines contributes to the growing field of immunotherapy, which seeks to harness the body’s immune system to combat cancer.

Immunotherapy: He is engaged in research focused on immunotherapy approaches for cancer treatment, highlighting his commitment to improving patient outcomes.

Cancer-Related Inflammation: Understanding the role of inflammation in cancer progression is a critical area of his research, as it can lead to new therapeutic targets.

Tumor Metastasis: His interest in tumor metastasis is vital for understanding how cancer spreads and devising strategies to prevent it.

Conclusion

Dr. Hadi Hassannia’s extensive research experience, impressive publication record, and technical skills make him an exceptional candidate for the Best Researcher Award. His contributions to cancer research, particularly in immunotherapy and vaccine development, demonstrate his potential to impact the field significantly and advance medical science.

 

Publication Top Notes

  • CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice – Cited by: 165, Year: 2017 🧬
  • Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles – Cited by: 85, Year: 2016 📉
  • Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine – Cited by: 76, Year: 2020 💉
  • Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway – Cited by: 72, Year: 2019 🚀
  • Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine – Cited by: 67, Year: 2020 ⚔️
  • Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice – Cited by: 67, Year: 2018 🌱
  • Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model – Cited by: 59, Year: 2018 🌼
  • Myeloid-derived suppressor cells in B cell malignancies – Cited by: 59, Year: 2015 🦠
  • FOXP3 and TGF-β gene polymorphisms in allergic rhinitis – Cited by: 54, Year: 2011 🌿
  • Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet‐rich plasma composite nanofibers – Cited by: 53, Year: 2020 🧪

 

Peng Zhang | Biological Science | Best Researcher Award

Posted on by ScienceFather

Dr. Peng Zhang | Biological Science | Best Researcher Award

Assistant Professor, Tianjin University of Technology, China

Dr. Peng Zhang is an Assistant Professor at the Life and Health Intelligent Research Institute, Tianjin University of Technology. With a strong focus on understanding gut microbiota and its impact on health, Dr. Zhang combines expertise in natural product research with advanced omics technologies. His work explores innovative ways to improve bioavailability and efficacy of therapeutic agents. 🌟

Publication Profile

Strengths for the Award:

  1. Innovative Research Focus: Peng Zhang’s work on natural products, drug delivery systems, and the role of gut microbiota in health demonstrates a high level of innovation and relevance in the field of life and health sciences.
  2. Significant Publications: Zhang has a strong publication record in reputable journals, including Journal of Functional Foods, Journal of Agricultural and Food Chemistry, and The ISME Journal. His research on gut microbiota and its impact on health conditions showcases his expertise and contributions to the field.
  3. Active Projects: Leading national projects funded by the National Natural Science Foundation of China, Zhang’s research includes high-impact topics like antibiotic resistance and its effects on gut microbiota. This aligns with current global health challenges.
  4. Diverse Experience: Zhang’s experience spans from studying the effects of natural products on obesity to the development of nanotechnology-based drug delivery systems, indicating a broad and applied approach to research.

Areas for Improvement:

  1. Broader Impact and Outreach: While Zhang’s research is impactful, expanding efforts to disseminate findings to a wider audience, including the general public and policymakers, could enhance the societal impact of his work.
  2. Collaborations and Networking: Increasing collaborations with international researchers and institutions could further strengthen his research’s global relevance and visibility.
  3. Grant and Project Diversification: Although Zhang has led and participated in significant projects, diversifying funding sources and project scopes might provide additional opportunities for groundbreaking research.

Education

Dr. Zhang earned his PhD from Nankai University, Tianjin, China, in 2021, where he developed models to study the role of gut microbiota in health crises caused by antibiotics. Prior to this, he completed his graduate studies at Hainan University, Haikou, China, focusing on the effects of dietary compounds on obesity. 🎓

Experience

2022 – Present: Assistant Professor, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin, China. Research includes purifying natural products and developing nanotechnology-based drug delivery systems. 🔬2017 – 2021: PhD student, Nankai University, Tianjin, China. Developed models to study antibiotic exposure and drug-resistant bacteria. 🧪2015 – 2017: Graduate student, Hainan University, Haikou, China. Examined effects of Luo Han Guo on obesity. 🌿

Research Focus

Dr. Zhang’s research primarily investigates the role of natural products in alleviating inflammatory diseases and improving gut health. His projects include:

Purifying Natural Products: Studying polysaccharides and polyphenols from medicinal foods to understand their impact on inflammatory diseases and gut microbiota. 🌱Drug Delivery Systems: Developing nanotechnology-based encapsulation systems to enhance the bioavailability of active compounds. 🚀

Awards and Honours

Dr. Zhang’s contributions to the field are recognized through various awards and honors. Notable mentions include his significant contributions to understanding the interactions between gut microbiota and therapeutic agents. 🏅

Publications Top Note

Biological Science, Biological Research, Life Sciences

  1. Polysaccharides isolated from Hibiscus sabdariffa L. mitigate intestinal radiation injury, Journal of Functional Foods, 2024.
  2. Polysaccharide Isolated from Agaricus blazei Murill Alleviates Intestinal Ischemia/Reperfusion Injury, Journal of Agricultural and Food Chemistry, 2024.
  3. The Gut Microbiota Contributes to Systemic Responses and Liver Injury in Gut-Derived Sepsis, Microorganisms, 2023.
  4. Porphyromonas gingivalis exacerbates alcoholic liver disease, Journal of Clinical Periodontology, 2023.
  5. Gut microbiota exaggerates triclosan-induced liver injury, Journal of Hazardous Materials, 2022.

 

Conclusion:

Peng Zhang is a highly qualified candidate for the Research for Best Researcher Award. His innovative research, strong publication record, and leadership in significant projects underscore his contributions to the field. Addressing areas for improvement, such as expanding outreach and fostering international collaborations, could further enhance his impact and recognition in the global research community.

 

Roger KoggeEnang | Soil Science | Best Researcher Award

Posted on by ScienceFather

Dr. Roger Kogge Enang | Soil Science | Best Researcher Award

Dr. Gabriel Espinosa Carrasco, University of Dschang, Cameroon

Dr. Roger Kogge Enang is a strong candidate for the Best Researcher Award due to his extensive background and contributions in soil science and environmental research. Here’s why he stands out:

Publication profile

Orcid

Extensive Research Output:

Since 2016, Dr. Enang has been actively publishing, with at least two scientific articles per year. His research spans various critical areas in soil science, including soil classification, nutrient cycling, and pollution remediation.

Educational Background:

He holds a Ph.D. and MSc in Soil Science, and a BSc in Chemistry, with a specialization in environmental chemistry and soil fertility. His academic credentials underpin his solid research foundation.

Diverse Research Interests:

His research covers vital topics such as soil mineralogy, soil organic matter, and digital soil mapping. He has contributed significantly to understanding soil properties and their implications for agriculture and environmental management.

Professional Involvement:

Dr. Enang is an active member of several professional organizations, including the Cameroon Soil Science Society and the International Network on Soil Pollution. His roles in these organizations reflect his commitment to advancing the field.

Field and Laboratory Experience:

His practical experience includes extensive soil surveys, experimental design, and advanced laboratory analyses. This hands-on expertise enhances the applicability and impact of his research findings.

Notable Publications:

Dr. Enang has published numerous peer-reviewed articles in reputable journals, demonstrating his ability to contribute valuable knowledge to the scientific community.

Given his track record of impactful research, extensive publications, and professional dedication, Dr. Roger Kogge Enang is highly suitable for the Best Researcher Award.

 

Shikun Ge | Engineering antibody | Excellence in Academia Award

Posted on by ScienceFather

Dr. Shikun Ge | Engineering antibody | Excellence in Academia Award

Dr. Shikun Ge, University of Minho, Portugal

Dr. Shikun Ge, born on May 6, 1990, in China, is a distinguished researcher in immunology, biochemistry, and veterinary medicine. Currently pursuing a PhD in Biology at the University of Minho, Dr. Ge has previously earned a Master in Veterinary Medicine from South China Agricultural University and a Bachelor in Veterinary Medicine from Liaocheng University. Her expertise spans immunization, antibody engineering, and veterinary infectious diseases. An accomplished scientist, she has received accolades such as the International Young Scientist Award (2023) and has published extensively on innovative antibody technologies.

Publication Profile

Google Scholar

🎓 Education and Training

Shikun Ge, born on May 6, 1990, in China, is a PhD candidate in Biology at the University of Minho since July 2019. He holds a Master’s in Veterinary Medicine from South China Agricultural University (2018) and a Bachelor’s in Veterinary Medicine from Liaocheng University (2015).

🏅 Honours and Awards

Ge has received the International Young Scientist Award (2023) and was recognized in the Frontrunner 5000 Top Articles in Outstanding S&T Journals of China (2021).

Research Focus

Dr. Shikun Ge’s research primarily focuses on veterinary medicine, immunology, and infectious diseases. Her work encompasses animal disease models, antibody engineering, phage display technology, and immunization. Dr. Ge has made significant contributions in diagnosing and neutralizing canine parvovirus using IgY-scFv, developing anti-SARS-CoV-2 antibodies, and characterizing porcine pestivirus infections. Additionally, her research includes the evaluation of IgY preparation methods and the expression of inflammation-related genes. Her diverse expertise and innovative approaches in antibody generation highlight her impact on veterinary infectious diseases and immunological studies. 📚🔍

 

Publication Top Notes

  • Identification of atypical porcine pestivirus infection in swine herds in China – 58 citations, 2017 🌐
  • Canine Parvovirus is diagnosed and neutralized by chicken IgY-scFv generated against the virus capsid protein – 25 citations, 2020 🐕
  • Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus – 18 citations, 2022 🦠
  • Expression of inflammation-related genes in the lung of BALB/c mice response to H7N9 influenza A virus with different pathogenicity – 9 citations, 2016 🧪
  • Evaluation of different IgY preparation methods and storage stability as potential animal feed supplement – 8 citations, 2020 🥚
  • Expression profile and tissue-specific distribution of the receptor-interacting protein 3 in BALB/c mice – 7 citations, 2016 🧬
  • Distinct expression profile and histological distribution of NLRP3 inflammasome components in the tissues of Hainan black goat suggest a site-specific role in the inflammatory response – 6 citations, 2017 🐐
  • The domestic hen – 5 citations, 2021 🐓
  • Generation and evaluation of anti-mouse IgG IgY as secondary antibody – 4 citations, 2020 🐭
  • Generation and evaluation of IgY-scFv based mimetics against canine parvovirus – 3 citations, 2021 🦠
  • Immunization of hens – 1 citation, 2021 🐔
  • Chimerism of avian IgY‐scFv and truncated IgG‐Fc: A novel strategy in cross‐species antibody generation and enhancement – 2024 🦢

Ali Reza Khosravi | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Ali Reza Khosravi | Immunology and Microbiology | Best Researcher Award

Prof Dr Ali Reza Khosravi, University of Tehran, Iran

Dr. Ali Reza Khosravi, DVM, MPH, PhD, is a Professor at the University of Tehran, leading its Mycology Research Center. His expertise in medical mycology spans fungal immunology, antifungal drugs, and immunomodulatory agents. Dr. Khosravi has authored several influential books on fungal infections and allergies and is a distinguished member of ISHAM and Iranian societies in immunology and mycology. Recognized with multiple awards, including Iran’s top researcher accolades, he continues to advance fungal immunology globally. 🍄

Publication profile

orcid

Education

Dr. Ali Reza Khosravi holds a diverse academic background. He earned his DVM from the University of Tehran in 1985, focusing on fish skin ulcer caused by Aspergillus species under the guidance of Prof. B. Mokhayer. Dr. Khosravi then pursued an MPH from Tehran University of Medical Sciences in 1988. In 1992, he completed his PhD in Medical Mycology at Tehran University of Medical Sciences, researching dermatophyte antigens and immunity to dermatophytosis under the supervision of Prof. M. Emami and Prof. H. Tadjbakhsh. He further honed his expertise through fellowships in Fungal Immunology at the University of Sao Paolo, Brazil, and Fungal Allergy and Immunology at the University of Leeds, UK. 🍄

Experience

Since 1992, Dr. Ali Reza Khosravi has been dedicated to academia at the University of Tehran, Iran. Starting as an Assistant Professor from 1992 to 1996, he advanced to the position of Associate Professor from 1996 to 2001. Since 2001, he has held the prestigious title of Professor, continuing his impactful research and mentorship at the University. Dr. Khosravi’s career spans over three decades of commitment to mycology research, focusing on fungal immunology, antifungal drugs, and immunomodulatory agents. His contributions have earned him recognition as a leading authority in his field, bolstered by numerous awards and affiliations with international mycological societies. 🎓

Honors

Dr. Ali Reza Khosravi has been recognized with prestigious awards throughout his career, underscoring his exceptional contributions to veterinary and medical mycology. His accolades include the Award of the First Ranked Professor in Iran (2008), the Award of the First Ranked Researchman in Iran (2004), and multiple honors as the top researcher at the University of Tehran (2001, 2004). Dr. Khosravi’s scholarly achievements were also celebrated internationally, with awards for Best Presented Papers at the International Veterinary Congress in Rio De Janeiro, Brazil (1992), and Top Presented Papers at the Asia Pacific International Congress in Penang, Malaysia (2004). 🏆

Research focus

Dr. Ali Reza Khosravi’s research focuses on diverse aspects of medical mycology and fungal immunology, exploring antifungal agents, immunomodulatory therapies, and the susceptibility profiles of fungal pathogens. His contributions span from investigating the chemical compositions of natural compounds against fish fungal infections to evaluating the antifungal potentials of essential oils and their combinations with conventional drugs. Dr. Khosravi’s work is pivotal in understanding fungal diseases’ mechanisms and developing novel therapeutic approaches 🍄.

Publication top notes

Biomimetic functionalized metal organic frameworks as multifunctional agents: Paving the way for cancer vaccine advances

Disseminated protothecosis: Case report and review of the literature

Actinomyces in Hand: An Unusual Cause of Osteomyelitis

Antifungal susceptibility profile of yeasts isolated from the oral cavity of cats

Chemical composition and in vitro antifungal activity of Sambucus ebulus and Actinidia deliciosa on the fish pathogenic fungus, Saprolegnia parasitica

Potential antifungal impact of citral and linalool administered individually or combined with fluconazole against clinical isolates of Candida krusei

Intrinsic Oncolytic Activity of Hoshino Mumps Virus Vaccine Strain Against Human Fibrosarcoma and Cervical Cancer Cell Lines

The efficacy of zymosan in pro-inflammatory cytokine production by peritoneal macrophages of melanoma-bearing mice

Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals.

Chitin-Induced Airway Epithelial Cell Innate Immune Responses Are Inhibited by Carvacrol/Thymol

Maxwell Hubert Antwi | Immunology | Best Researcher Award

Posted on by ScienceFather

Mr. Maxwell Hubert Antwi | Immunology | Best Researcher Award

Mr. Maxwell Hubert Antwi, Koforidua Technical University, Ghana

Dr. Maxwell Hubert Antwi is a dedicated researcher and educator in the field of Medical Laboratory Science. He holds a PhD and serves as an Assistant Lecturer at Koforidua Technical University, Ghana. His research interests encompass immunology, proteomics, global health, and infectious diseases like malaria. Dr. Antwi has authored several impactful publications, contributing significantly to the scientific community’s understanding of various health issues. Beyond academia, he actively engages in community service and professional development activities. With proficiency in Microsoft Office and Python programming, Dr. Antwi is also known for his leadership qualities and fluency in English and French. 🌍🔬

Publication Profile:

Orcid

Google Scholar

 

Education:

Maxwell Hubert Antwi pursued his academic journey with fervor, obtaining an MSc in Medical Laboratory Science from Kwame Nkrumah University of Science and Technology, Ghana, in 2018. His research delved into the intricate relationship between Vitamin D deficiency and cytokines (IL 10, TNF-alpha, IFN-gamma), under the guidance of esteemed Professor Samuel Asamoah Sakyi. Prior to this, he earned a BSc in Medical Laboratory Science from the University of Ghana in 2012. His undergraduate thesis, supervised by Professor E.K Wiredu, focused on the prevalence of unsatisfactory Pap smear reports and the potential association with cancer cell presence. 🎓

Certificate:

Maxwell Hubert Antwi expanded his expertise through a certificate program in Civil Society Management, a collaborative effort by the Young African Leadership Initiative (YALI-West Africa) and the Ghana Institute of Management and Public Administration (GIMPA). 🌍 Focusing on environmental sustainability, his research under the guidance of the Regional Leadership Center-West Africa (YALI-GIMPA) centered on single-use plastic waste management. This initiative showcased his commitment to addressing pressing global challenges and his dedication to making a positive impact on society. 🌱 Through this program, he honed his leadership skills and gained valuable insights into fostering community-driven solutions for a cleaner, healthier planet.

Awards and Honors:

Maxwell Hubert Antwi’s exceptional achievements have been recognized through prestigious honors and awards. In 2023, he received the Presidential Honour for Distinguished Service Award for his remarkable contributions during the COVID-19 pandemic, bestowed by the President of the Republic of Ghana at the Jubilee House. 🏅 Additionally, his leadership prowess was evident in 2019 when he was part of the winning team, earning the Young African Leadership Initiative (YALI) Pitching Award during Cohort 14 Training at the Regional Leadership Center-West Africa-Accra. 🌟 Antwi’s academic excellence was evident early on, as he was named the Best graduating student at The Comforter Junior High School in Kumasi, Ghana, in 2003. 🎓

 

Teaching Experience :

Maxwell Hubert Antwi has demonstrated a strong commitment to education through his extensive teaching experience in the medical field. 📚 Joining Koforidua Technical University’s Medical Laboratory Science Department in 2021 as an Assistant Lecturer, he imparted knowledge to undergraduate students in various courses, including Haematology, Medical Immunology, and Health and Safety. His dedication continued in previous years, where he engaged students at different levels of their academic journey, fostering learning environments conducive to growth and development. Antwi’s teaching expertise also extended beyond the university setting, as he contributed to the education of nursing students at Navrongo Community Nursing College. 🎓 His hands-on approach and commitment to student success exemplify his passion for teaching and mentorship.

 

Research Focus:

Maxwell Hubert Antwi’s research primarily focuses on public health, with a particular emphasis on infectious diseases and epidemiology. 🦠 His studies encompass a wide range of topics, including the prevalence and determinants of various health conditions such as Vitamin D deficiency, cancer burden attributable to risk factors, and the impact of infectious diseases like malaria and COVID-19. 🩺 Antwi’s work contributes significantly to understanding disease patterns, risk factors, and potential interventions, thereby aiding in the development of strategies for disease prevention and management. 🌍 Through his research endeavors, he strives to make meaningful contributions to global health and well-being.

Publication Top Notes:

  1. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …. 🩺 Cited by: 873, Year: 2022
  2. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 🌍 Cited by: 339, Year: 2022
  3. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 🔬 Cited by: 20, Year: 2023
  4. Non-life-threatening adverse reactions from COVID-19 vaccine; a cross-sectional study with self-reported symptoms among Ghanaian healthcare workers 💉 Cited by: 16, Year: 2021
  5. Prevalence and determinants of low testosterone levels in men with type 2 diabetes mellitus; a case-control study in a district hospital in Ghana 📉 Cited by: 10, Year: 2021
  6. A comparative analysis of the knowledge and stigmatizing attitude of Ghanaians and Nigerians towards COVID-19 survivors 🤝 Cited by: 7, Year: 2021
  7. Vitamin D deficiency is common in Ghana despite abundance of sunlight: A multicentre comparative cross-sectional study ☀️ Cited by: 6, Year: 2021
  8. Prevalence of Unsatisfactory Pap Smear and Associated Clinical History and Diagnosis in a Tertiary Teaching Hospital in Ghana 🩺 Cited by: 2, Year: 2019
  9. Assessment of platelet numbers and prevalence of thrombocytopenia among children with severe malaria at a tertiary teaching hospital🦟 Cited by: 1, Year: 2021
  10. Chemokine Receptors Expression on Peripheral CD4-Lymphocytes in Rheumatoid Arthritis: CD4+ CD183+ As A Diagnostics Marker for Disease Activity in Rheumatoid Arthritis 🔄 Year: 2024